Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06517446
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-08
Brief Title:
Optokinetic Virtual Reality Stimulation in Unilateral Vestibular Hypofunction
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effect of Optokinetic Virtual Reality Stimulation in Unilateral Vestibular Hypofunction Patients
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study Prof Dr It will be performed on patients diagnosed with UVH who apply to Mete İşeri Ear Nose and Throat Diseases Clinic and Güneşli Erdem Hospital Ear Nose Throat and Vestibular Rehabilitation Unit Participants were selected by simple randomization sealed envelope method will be divided into two groups control group and study group Criteria for inclusion in the study While he was diagnosed with unilateral vestibular hypofunction with the VNG test was between the ages of 18-65 was in the A class in the System Usability Scale SCS and had a percentage range between 96-100 Exclusion criteria of the study Bilateral vestibular hypofunction visual impairment neurological disorder and inability to communicate To the control group A conventional rehabilitation program based on structured Cawthorne Cooksey exercises will be applied for 45 minutes with the support of a physiotherapist once a week for 8 weeks As for the working group In addition to the program of the participants in the vestibular exercise group optokinetic stimulation will be given through oculus glasses Application will be made 1 day a week for 8 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None